MedTrace Logo

AI Driven National Platform for CT cOronary Angiography for clinicaL and industriaL applicatiOns Registry

NCT05509010 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 8000

Last updated 2022-08-19

No results posted yet for this study

Summary

The overall aim is to build an AI driven national Platform for CT cOronary angiography for clinicaL and industriaL applicatiOns (APOLLO) for automated anonymization, reporting, Agatston scoring and plaque quantification in CAD. It is a "one-stop" platform spanning diagnosis to clinical management and prognosis, and aid in predicting pharmacotherapy response.

Conditions

Interventions

PROCEDURE

CTCA

CTCA is performed as part of routine care procedure.

Sponsors & Collaborators

  • Agency for Science, Technology and Research

    collaborator OTHER

  • National Heart Centre Singapore

    lead OTHER

Principal Investigators

  • Liang Zhong · National Heart Centre Singapore

Eligibility

Min Age
21 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-10-01
Primary Completion
2027-12-31
Completion
2027-12-31

Countries

  • Singapore

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05509010 on ClinicalTrials.gov